France· FR:60897889
INDUCTOS 1,5 mg/ml, poudre, solvant et matrice pour matrice implantable
A medicinal product containing dibotermine alfa, registered in France by MEDTRONIC BIOPHARMA (PAYS-BAS).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DIBOTERMINE ALFA
- Manufacturer
- MEDTRONIC BIOPHARMA (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009550702211 flacon en verre de 4 mg + 1 flacon en verre de 10 ml + 2 matrices de 2,5 x 5 cm sous plaquettes PVC + 2 seringues + 2 aiguilles
- cip1334009564511591 flacon en verre de 12 mg + 1 flacon en verre de 10 ml + 1 matrice de 7,5 x 10 cm sous plaquette PVC + 2 seringues + 2 aiguilles
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dibotermine alfa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandInductOs 1.5 mg/ml powder, solvent and matrix for implantation matrixMedtronic BioPharma B.V.
- BelgiumInductOs 1.5 mg/mlMedtronic Biopharma
- SwitzerlandInductOs 1.5 mg/ml, poudre 12 mg, solvant et matrice pour matrice pour implantationMedtronic BioPharma Sàrl
- CzechiaINDUCTOSMedtronic BioPharma B.V., Heerlen
- FinlandInductosMedtronic BioPharma B. V.
- United KingdomInductOs 12mg powder and solvent and matrix for implantation matrixMedtronic Ltd
- SwedenInductOs 1,5 mg/ml Pulver, vätska och matrix till matrix för implantationMedtronic BioPharma B.V.
- IcelandInductOsMedtronic BioPharma B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inductos
- Liechtenstein · Inductos
- Norway · Inductos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d024e36-77f3-4fff-b960-92572c006593 GET /v1/drugs/2d024e36-77f3-4fff-b960-92572c006593?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60897889",
"date_amm": "2002-09-09",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/02/226",
"substance": "DIBOTERMINE ALFA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant et matrice pour matrice implantable",
"voies_administration": "implantation",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about dibotermine alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.